Genevia Lifesciences AG is now ready for the next growth phase and is at the seed stage.

Founded in 2018, the company spent three years conducting scientific research and analysis, creating and testing two product formulas, delivering products and systems, developing brands, and planning a product pipeline.

Genevia Lifesciences AG is a non-listed Swiss public company whose mission is to extend and improve human life.

To learn more and receive the investment Precis, please contact at investors@genevia.com